Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?
Sciarra
A
A
Department of Urology 'U. Bracci', University La Sapienza, Rome, Italy. sciarrajr@hotmail.com
Mariotti
G
G
Gentile
V
V
Voria
G
G
Pastore
A
A
Monti
S
S
Di Silverio
F
F
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D006801:Humans; D008297:Male; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000473:pathology*; D009490:Neurosecretory Systems / Q000166:cytology*; D011467:Prostate / Q000166:cytology* / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000473:pathology; D019048:Prostatic Intraepithelial Neoplasia / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*
D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor